Advertisement

Topics

Vernalis cough and cold drug knocked-back by FDA

05:13 EDT 7 Aug 2017 | Pharmafile

Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, known as CCP-08, has fallen foul of the issues that led to CCP-07 being rejected earlier this year, in April.

read more

Original Article: Vernalis cough and cold drug knocked-back by FDA

NEXT ARTICLE

More From BioPortfolio on "Vernalis cough and cold drug knocked-back by FDA"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...